Braveheart Bio, Inc.

BRVE

Insiders bought in the last twelve months.

18.71 0.84 −4.30%
Market cap
$1.8B
P/E
—
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a
Jun '25 Dec '25 Mar '26 Jun '26
ROE
— — — 0.00%
ROA
— — — 0.00%
ROIC
— 0.00% 0.00% 0.00%
Return on Tangible Assets
— 0.00% 0.00% (29.16%)
Free Cash Flow per Share
0.00 — 0.00 (2.99)
Free Cash Flow
— — — (22.14)
Other line items
Cash ROIC
— 0.00% 0.00% (81.61%)
Average Days of Payables
— 0.00 0.00 0.00
Tax Rate
— — — 0.00
Selling, General and Administrative Expense of Revenue
— — — 0.00%
Operating CF/Net income
— — — 0.66
Depreciation/Fixed assets
— — 0.00 0.00
Revenue per Share
0.00 — 0.00 0.00
Operating CF per Share
0.00 — 0.00 (2.99)
Capex per Share
0.00 — 0.00 0.00

Fold the line items

Columns are period end dates · fundamentals updated 1 Oct 2026